The 2011 Leading Life Science Intermediates Companies R&D Expenditures and Major Programs

Date: October 22, 2010
Pages: 32
Price:
US$ 1,850.00 US$ 1,572.50
Publisher: VPGMarketResearch.com
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: L023F845D5AEN
Leaflet:

Download PDF Leaflet

The 2011 Leading Life Science Intermediates Companies R&D Expenditures and Major Programs
Global PDF: US$ 3,900.00

For each company, the report provides:
  • Estimated R&D budget.
  • Research facilities and staff.
  • New technologies, products and applications in development.
The companies analyzed in the report: BASF, Bayer/Lanxess, Cambrex, Clariant, DowPharma, DSM, Evonik, Lonza, Novasep, and Rhodia.

Contains 32 pages
Skip to top


Ask Your Question

The 2011 Leading Life Science Intermediates Companies R&D Expenditures and Major Programs
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: